
Ekorab 20mg Injection
Marketer
Ekasar Lifescience
Salt Composition
Rabeprazole (20mg)
Overview Ekorab 20mg Injection
GastriCalm 20mg Injection effectively reduces stomach acid production. Indicated for various acid-related gastrointestinal disorders, including heartburn, indigestion, peptic ulcers, and other conditions stemming from excessive acid secretion, it offers rapid symptom relief. This fast-acting injection is also used prophylactically against stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's administered intravenously by a healthcare professional only when deemed superior to oral administration by your physician. Dosage and treatment duration are individualized based on your condition and response. Optimal results are achieved by adopting a diet of smaller, more frequent meals, while avoiding caffeine, spicy foods, and fatty meals. Common, usually mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year, may increase bone fracture risk, especially at higher doses. Discuss bone health strategies, such as calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low magnesium) has been reported in some patients after three months or more of treatment, potentially causing fatigue, confusion, dizziness, muscle spasms, and arrhythmia. Your doctor may monitor your magnesium levels. GastriCalm 20mg Injection is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or existing osteoporosis. Pregnant or lactating women should consult their physician before use. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery if experiencing dizziness or drowsiness.
Uses of Ekorab 20mg Injection
Managing acid reflux and peptic ulcers.
Major Benefits of Ekorab 20mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Ekorab 20mg Injection:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flatulence
- Diarrhea
- Stomach pain
- Thrombophlebitis
How to use Ekorab 20mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Ekorab 20mg Injection works:
Gastric acid production is decreased by the proton pump inhibitor (PPI) Ekorab 20mg Injection, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Ekorab 20mg Injection and alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Ekorab 20mg Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Ekorab 20mg Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Ekorab 20mg Injection on driving ability is undetermined. Refrain from driving if any symptoms impair concentration or reaction time.
KidneySAFE IF PRESCRIBED
Ekorab 20mg Injection presents no safety concerns for patients with renal impairment; dose modification is unnecessary.
LiverCAUTION
Patients with severe hepatic impairment should use Ekorab 20mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Ekorab 20mg Injection :
Omit a dose of Ekorab 20mg Injection? Seek your physician's advice.
Facts to Know About Ekorab 20mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Gastric acid suppressants |
